Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.

Saved in:
Bibliographic Details
Title: Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.
Authors: Williams BG; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Barrett JR; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Scott JB; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Rigby CA; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Cagiada M; Department of Statistics, University of Oxford, Oxford, UK; Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark., Quinkert D; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., McHugh K; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Huhn A; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Burnap SA; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Gourjault C; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Byrne F; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Raghavan SSR; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Rodrigues A; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Bergamaschi L; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Balzarotti B; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Watson S; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Miller N; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., King LDW; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Donnellan FR; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Gladstone CA; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Paterson J; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Scalabrino S; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Silk SE; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Salkeld J; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Minassian AM; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Skinner K; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Struwe WB; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Deane CM; Department of Statistics, University of Oxford, Oxford, UK., Reece ST; Kymab Ltd., a Sanofi Company, Babraham Research Campus, Cambridge, UK., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Draper SJ; Department of Paediatrics, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: simon.draper@paediatrics.ox.ac.uk.
Source: Immunity [Immunity] 2026 Jun 12. Date of Electronic Publication: 2026 Jun 12.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-4180
DOI:10.1016/j.immuni.2026.05.012